Cornerstone Robotics (CSR) has announced the first formal clinical investigation of its Hong Kong-developed surgical robotic system at Portsmouth Hospitals University NHS Trust (PHU),...
Everest Medicines (HKG: 1952) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shanghai. The event...
ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic quality assurance. Leveraging phage-like...
- Kidney Disease Treatment into a New Era of Precision Management
At the 62nd Congress of the European Renal Association (ERA 2025), Everest Medicines presented...
At the 62nd European Renal Association Congress (ERA 2025), Everest Medicines unveiled new clinical data on EVER001 (previously known as XNW1011), a next-generation covalent...
In 2025, the policies regarding traditional Chinese medicine (TCM) in Mainland China are being continuously optimized, providing broader opportunities for the consumer TCM market....
